SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

UBS Raises Iovance Biotherapeutics Price Target to $8 From $7

Valid market news retained in the public archive without immediate LiveCast distribution.

IOVA

Related stories